Our Sustaining Members

In order to ensure its financial sustainability and, at the same time, its autonomy, SPCC has created the SPCC Sustaining Membership Model, a collaboration with Pharmaceutical and Medical technology companies in the Life Science sector, and open also to Foundations, to encourage and support the Purpose, Vision and Mission of SPCC and its relevant pillars and strategic tools of dissemination and communication. 

A number of mainly pharmaceutical companies have become “Sustaining Members” of SPCC by agreeing to provide an annual fee according to various levels of the programme and accepting the unrestricted nature of such support. SPCC has three different levels of commitment (Platinum, Gold or Silver) and these sponsorship levels and annual fees are proposed for a period of three years.

Platinum Sponsors

	AstraZeneca Oncology https://www.astrazeneca.com/our-therapy-areas/oncology.html
	Pfizer Oncology https://www.pfizer.com/science/oncology-cancer

Gold Sponsors

	Bristol Myers Squibb www.bms.com or https://www.immunooncology.com
	Fresenius Kabi https://www.fresenius-kabi.com/therapeutic-areas/oncology
	Lilly https://www.lillyoncology.com/
	Mundipharma  https://www.mundipharma.com/

Silver Sponsors

	Exact Sciences https://www.exactsciences.com/
	Menarini Stemline https://stemline.com/
	Novartis https://www.novartis.com/
	Roche  https://www.roche.com/.../oncology.htm
	Sanofi https://www.sanofi.com/en
	Seagen https://www.seagen.com/